These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35819592)

  • 1. Suppression of nitric oxide synthase aggravates non-alcoholic steatohepatitis and atherosclerosis in SHRSP5/Dmcr rat via acceleration of abnormal lipid metabolism.
    Sato I; Yamamoto S; Kakimoto M; Fujii M; Honma K; Kumazaki S; Matsui M; Nakayama H; Kirihara S; Ran S; Usui S; Shinohata R; Kitamori K; Hirohata S; Watanabe S
    Pharmacol Rep; 2022 Aug; 74(4):669-683. PubMed ID: 35819592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model.
    Watanabe S; Kumazaki S; Yamamoto S; Sato I; Kitamori K; Mori M; Yamori Y; Hirohata S
    Int J Exp Pathol; 2018 Dec; 99(6):282-294. PubMed ID: 30680827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.
    Horai Y; Utsumi H; Ono Y; Kishimoto T; Ono Y; Fukunari A
    Int J Exp Pathol; 2016 Feb; 97(1):75-85. PubMed ID: 27037502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of ouabagenin, a novel liver X receptor agonist, on atherosclerosis in nonalcoholic steatohepatitis in SHRSP5/Dmcr rat model.
    Yamamoto S; Sato I; Fujii M; Kakimoto M; Honma K; Kirihara S; Nakayama H; Fukuoka T; Tamura S; Ueda M; Hirohata S; Watanabe S
    Can J Physiol Pharmacol; 2023 Sep; 101(9):455-465. PubMed ID: 37224568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats.
    Watanabe S; Kumazaki S; Kusunoki K; Inoue T; Maeda Y; Usui S; Shinohata R; Ohtsuki T; Hirohata S; Kusachi S; Kitamori K; Mori M; Yamori Y; Oka H
    J Atheroscler Thromb; 2018 May; 25(5):439-453. PubMed ID: 29162773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in SHRSP5/Dmcr rat model.
    Yamamoto S; Sato I; Fukuhama N; Akiyama N; Sakai M; Kumazaki S; Ran S; Hirohata S; Kitamori K; Yamori Y; Watanabe S
    Exp Mol Pathol; 2020 Jun; 114():104437. PubMed ID: 32246926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic NOS inhibition accelerates NAFLD progression in an obese rat model.
    Sheldon RD; Padilla J; Jenkins NT; Laughlin MH; Rector RS
    Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G540-9. PubMed ID: 25573175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant action of xanthine oxidase inhibitor febuxostat protects the liver and blood vasculature in SHRSP5/Dmcr rats.
    Kakimoto M; Fujii M; Sato I; Honma K; Nakayama H; Kirihara S; Fukuoka T; Ran S; Hirohata S; Kitamori K; Yamamoto S; Watanabe S
    J Appl Biomed; 2023 Jun; 21(2):80-90. PubMed ID: 37376883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective autophagy associated with iron overload aggravates non-alcoholic steatohepatitis via ferroptosis.
    Honma K; Kirihara S; Nakayama H; Fukuoka T; Ohara T; Kitamori K; Sato I; Hirohata S; Fujii M; Yamamoto S; Ran S; Watanabe S
    Exp Biol Med (Maywood); 2023 Jul; 248(13):1112-1123. PubMed ID: 37646078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis.
    Wang W; Zhao C; Zhou J; Zhen Z; Wang Y; Shen C
    PLoS One; 2013; 8(10):e76538. PubMed ID: 24098525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacran, a sulfated polysaccharide, suppresses the absorption of lipids and modulates the intestinal flora in non-alcoholic steatohepatitis model rats.
    Goto M; Azuma K; Arima H; Kaneko S; Higashi T; Motoyama K; Michihara A; Shimizu T; Kadowaki D; Maruyama T; Otagiri M; Iohara D; Hirayama F; Anraku M
    Life Sci; 2021 Mar; 268():118991. PubMed ID: 33417955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study.
    Sonoda K; Kono Y; Kitamori K; Ohtake K; Shiba S; Kasono K; Kobayashi J
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHRSP5/Dmcr rats fed a high-fat and high-cholesterol diet develop disease-induced sarcopenia as nonalcoholic steatohepatitis progresses.
    Yamamoto S; Honma K; Fujii M; Kakimoto M; Kirihara S; Nakayama H; Kitamori K; Sato I; Hirohata S; Watanabe S
    Ann Anat; 2023 Aug; 249():152104. PubMed ID: 37209870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide mediates the insulin sensitizing effects of β-sitosterol in high fat diet-fed rats.
    Radika MK; Viswanathan P; Anuradha CV
    Nitric Oxide; 2013 Aug; 32():43-53. PubMed ID: 23624268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
    Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B
    Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in nitric oxide bioavailability shifts serum lipid content towards atherogenic lipoprotein in rats.
    Aluko EO; Omobowale TO; Oyagbemi AA; Adejumobi OA; Ajibade TO; Fasanmade AA
    Biomed Pharmacother; 2018 May; 101():792-797. PubMed ID: 29525675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female SHR have greater blood pressure sensitivity and renal T cell infiltration following chronic NOS inhibition than males.
    Brinson KN; Elmarakby AA; Tipton AJ; Crislip GR; Yamamoto T; Baban B; Sullivan JC
    Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R701-10. PubMed ID: 23883679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis].
    Nakajima T; Naito H
    Nihon Eiseigaku Zasshi; 2015; 70(3):197-204. PubMed ID: 26411937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous changes in high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis and those underlying molecular mechanisms in novel SHRSP5/Dmcr rat.
    Moriya T; Kitamori K; Naito H; Yanagiba Y; Ito Y; Yamagishi N; Tamada H; Jia X; Tsuchikura S; Ikeda K; Yamori Y; Nakajima T
    Environ Health Prev Med; 2012 Nov; 17(6):444-56. PubMed ID: 22407906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the nitric oxide pathway in cerebral arteries from spontaneously hypertensive rats.
    Briones AM; Alonso MJ; Hernanz R; Miguel M; Salaices M
    J Cardiovasc Pharmacol; 2002 Mar; 39(3):378-88. PubMed ID: 11862117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.